DOWN SYNDROME (TRISOMY 21)
Clinical trials for DOWN SYNDROME (TRISOMY 21) explained in plain language.
Never miss a new study
Get alerted when new DOWN SYNDROME (TRISOMY 21) trials appear
Sign up with your email to follow new studies for DOWN SYNDROME (TRISOMY 21), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial aims to clear Alzheimer's-Linked brain plaques in down syndrome
Disease control Not yet recruitingThis study tests whether donanemab can safely reduce amyloid plaques in the brains of adults with Down syndrome, who are at high risk for Alzheimer's disease. Sixty participants aged 35-50 will receive either donanemab or a placebo every 4 weeks for 12 months, followed by a 12-mo…
Matched conditions: DOWN SYNDROME (TRISOMY 21)
Phase: PHASE4 • Sponsor: Michael Rafii, MD, PhD • Aim: Disease control
Last updated Apr 24, 2026 16:06 UTC
-
Scientists probe trust wiring in down syndrome and fragile x
Knowledge-focused Not yet recruitingThis study looks at how people with Down syndrome or Fragile X syndrome decide who to trust. Researchers will use computer tasks and eye-tracking to measure how participants judge faces, behaviors, and whether someone is being honest. The goal is to understand the thinking patter…
Matched conditions: DOWN SYNDROME (TRISOMY 21)
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 26, 2026 06:30 UTC